176 related articles for article (PubMed ID: 6085389)
21. Inhibition of theophylline clearance by cimetidine but not ranitidine.
Powell JR; Rogers JF; Wargin WA; Cross RE; Eshelman FN
Arch Intern Med; 1984 Mar; 144(3):484-6. PubMed ID: 6322709
[TBL] [Abstract][Full Text] [Related]
22. A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine.
Kamali F; Howes A; Thomas SH; Ford GA; Snoeck E
Br J Clin Pharmacol; 1997 Feb; 43(2):201-4. PubMed ID: 9131955
[TBL] [Abstract][Full Text] [Related]
23. Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers.
Kann J; Krol GJ; Raemsch KD; Burkholder DE; Levitt MJ
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S968-73. PubMed ID: 6085386
[TBL] [Abstract][Full Text] [Related]
24. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
Aronoff GR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
[TBL] [Abstract][Full Text] [Related]
26. No effect of short term ranitidine intake on diclofenac pharmacokinetics.
Leucuţa A; Vlase L; Farcau D; Nanulescu M
Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028
[TBL] [Abstract][Full Text] [Related]
27. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
[TBL] [Abstract][Full Text] [Related]
28. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Romero A; Gómez F; Villamayor F; Ballesta A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
[TBL] [Abstract][Full Text] [Related]
30. Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration.
Smith SR; Kendall MJ; Lobo J; Beerahee A; Jack DB; Wilkins MR
Br J Clin Pharmacol; 1987 Mar; 23(3):311-5. PubMed ID: 3567045
[TBL] [Abstract][Full Text] [Related]
31. The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine.
Ene MD; Williamson PJ; Roberts CJ; Waddell G
Br J Clin Pharmacol; 1985 Apr; 19(4):423-7. PubMed ID: 3158325
[TBL] [Abstract][Full Text] [Related]
32. Safety aspects of long-term nitrendipine therapy.
Stoepel K; Deck K; Corsing C; Ingram C; Vanov SK
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1063-6. PubMed ID: 6085368
[TBL] [Abstract][Full Text] [Related]
33. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine increases the bioavailability of nitrendipine in patients with arterial hypertension.
Santos SR; Storpirtis S; Moreira-Filho L; Donzella H; Kirch W
Braz J Med Biol Res; 1992; 25(4):337-47. PubMed ID: 1342209
[TBL] [Abstract][Full Text] [Related]
35. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
Molin L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
[TBL] [Abstract][Full Text] [Related]
36. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
[TBL] [Abstract][Full Text] [Related]
37. Interaction between nifedipine and cardioactive drugs.
Haustein KO; Assmann I; Hüller G
Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):458-61. PubMed ID: 2272705
[TBL] [Abstract][Full Text] [Related]
38. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
39. The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.
Kubacka RT; Antal EJ; Juhl RP
Br J Clin Pharmacol; 1987 Jun; 23(6):743-51. PubMed ID: 3111514
[TBL] [Abstract][Full Text] [Related]
40. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
Knorr A; Stoepel K
Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
